Erratum to: Med Oncol (2013) 30:655 DOI 10.1007/s12032-013-0655-z
The authors would like to make changes in the Results section as follows:
-
To clarify the sentence in the discussion section: “we additionally recognize the potential confounding factor of differences in baseline Child class between both arms of the study”.
-
Figure 2: There is a typographical error in the age of the patient as it should be 57 and not 69 (born in 1953 and diagnosed in 2010).
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found under doi:10.1007/s12032-013-0655-z.
Rights and permissions
About this article
Cite this article
Abdel-Rahman, O., Abdel-Wahab, M., Shaker, M. et al. Erratum to: Sorafenib versus capecitabine in the management of advanced hepatocellular carcinoma. Med Oncol 32, 244 (2015). https://doi.org/10.1007/s12032-015-0688-6
Published:
DOI: https://doi.org/10.1007/s12032-015-0688-6